These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19699850)

  • 1. Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Lozano I; Rondan J; Avanzas P
    Am Heart J; 2009 Sep; 158(3):e39; author reply e41. PubMed ID: 19699850
    [No Abstract]   [Full Text] [Related]  

  • 2. Double jeopardy, double trouble.
    Blankenship JC
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):279-80. PubMed ID: 20665877
    [No Abstract]   [Full Text] [Related]  

  • 3. Embolic protection devices in saphenous percutaneous intervention.
    Morís C; Lozano I; Martín M; Rondán J; Avanzas P
    EuroIntervention; 2009 May; 5 Suppl D():D45-50. PubMed ID: 19736070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous intervention over the origin of a saphenous vein graft anastomosed with the St. Jude Medical Symmetry Aortic Connector System.
    Fuertes J; Lozano I; Turiel JM; Llosa JC; Suarez E; de la Tassa CM
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):103-6. PubMed ID: 14696167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revitalizing embolic protection in saphenous vein grafts.
    Satler LF
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 8. Approach to the patient with prior bypass surgery.
    Nguyen T; Pham L; Cheem TH; Douglas JS; Hermiller J; Grines C
    J Interv Cardiol; 2004 Oct; 17(5):339-46. PubMed ID: 15491339
    [No Abstract]   [Full Text] [Related]  

  • 9. The MGuard stent: current promises and limitations.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):642-3. PubMed ID: 20333654
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent.
    Ho PC; Leung CY
    J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools & techniques: Percutaneous intervention of saphenous vein graft lesions.
    Agostoni P; Voskuil M; Onsea K; Vermeersch P; Stella PR
    EuroIntervention; 2011 Nov; 7(7):878-9. PubMed ID: 22082583
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 13. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
    Kurowski V; Toelg R; Jain D; Richter C; Wiegand UK; Richardt G; Khattab AA
    Am J Cardiol; 2005 Sep; 96(5):681-4. PubMed ID: 16125495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should I treat critical stenosis of a saphenous venous graft to the posterior descending artery on the bifurcation site?
    Russo F; De Nittis G; Zerboni SC; Valli P; Galli M; Abdou SM; Sachdeva R
    EuroIntervention; 2014; 9(12):1478-82. PubMed ID: 24755389
    [No Abstract]   [Full Text] [Related]  

  • 16. Time from coronary artery bypass surgery does not affect outcome in patients treated with primary angioplasty for acute saphenous vein graft occlusion.
    van der Schaaf RJ; Vis MM; Sjauw KD; Koch KT; Baan J; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Heart; 2007 Mar; 93(3):381-2. PubMed ID: 17322522
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies.
    Haeck JD; Verouden NJ; Henriques JP; Koch KT
    Future Cardiol; 2009 Jul; 5(4):385-402. PubMed ID: 19656063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.
    Fischell T; Haller S; Ashraf K
    J Invasive Cardiol; 2005 Jun; 17(6):334-7. PubMed ID: 16003012
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel concept in endovascular stenting for the treatment of old severely degenerated saphenous vein graft in the urgent setting.
    Hendler A; Minha S; Krakover AR
    Catheter Cardiovasc Interv; 2010 May; 75(6):957-8. PubMed ID: 20091814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
    Toutouzas K; Takagi T; Colombo A
    J Invasive Cardiol; 2003 Dec; 15(12):722-4. PubMed ID: 14660828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.